ScholarWorks@SOONCHUNHYANG UNIVERSITY: Kim, Kyoung Ha

Detailed Information

Kim, Kyoung Ha (김경하)

College of Medicine (Department of Internal Medicine)

Research Area

Tel
E-mail
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Multiple myeloma:3||Guideline:3||Myelodysplastic syndrome:2||Venous thromboembolism:2||Chronic myeloid leukemia:2||Lymphoma:2||Antithymocyte globulin:1||Autoimmune diseases:1||Autologous:1||Autologous stem cell transplantation:1||BCRABL1 tyrosine kinase:1||Biomarker:1||Bleeding:1||Bloodless treatment:1||Bortezomib:1||Busulfan:1||Cachexia:1||Carcinoma, hepatocellular:1||Chronic monomyelocytic leukemia:1||Compartment syndrome:1||Consolidation:1||Copy neutral loss of heterozygosity (CNLOH):1||Copy number alterations:1||Core binding factorpositive acute myeloid leukemia:1||Cytarabine:1||Cytokines:1||Dalteparin:1||Deep vein thrombosis:1||Donor cell leukemia:1||Drug therapy:1||Drugrelated side effects and adverse reactions:1||Elderly AML:1||Etoposide:1||Extramedullary solitary plasmacytoma:1||Fludarabine:1||Gemcitabine:1||Ghrelin:1||Graft vs host disease:1||Hematoma:1||Hematopoietic stem cell transplantation:1||Hodgkin's lymphoma:1||Hypomethylating agent:1||Induction:1||Inflammatory myositis:1||Interstitial lung diseases:1||KIT:1||Korea:1||Korean:1||Leptin:1||Leukemia:1||Lung injury:1||Management:1||Metastasis:1||Methylprednisolone:1||Molecular response:1||Molecular targeted therapy:1||Mutation:1||Mutations:1||NonHodgkin’s:1||NonHodgkin’s lymphoma:1||Ovarian cancer:1||Oxaliplatin:1||Platinum resistant:1||Portal vein:1||Prevention:1||Prostate cancer:1||Proteintyrosine kinases:1||Pulmonary embolism:1||Reallife practice:1||Rectus sheath:1||Related donor:1||S1:1||Single nucleotide polymorphismbased karyotyping:1||Sorafenib:1||Stem cell Transplantation:1||Stem cell transplantation:1||Thrombosis:1||Treatmentfree remission:1||Tumor lysis syndrome:1||Tyrosine kinase inhibitors:1||Ultradeep sequencing:1||Urethral cancer:1||Venous Thromboembolism:1||Vinorelbine:1||acute lymphoblastic leukemia:1||alternative treatment:1||autologous stem cell transplantation:1||bortezomib:1||chronic myelogenous:1||cisplatin:1||de novo leukemic variant:1||dysbiosis:1||gemcitabinerefractory:1||gut microbiome:1||hepatic arterial infusion chemotherapy:1||hepatocellular carcinoma:1||high cost:1||indolent T cell lymphoma:1||indolent Tcell lymphoproliferative disease of gastrointestinal tracts:1||irondeficiency anemia (IDA):1||low grade T cell lymphoma:1||nextgeneration sequencing (NGS):1||pancreatic cancer:1||peripheral T cell lymphoma:1||side population:1||sorafenib:1||stem cells:1||young women:1||골반강 내 혈종:1||구획증후군:1||다발골수종:1||림프종:1||만성골수성백혈병:1||무수혈:1||복직근초 혈종:1||비호지킨림프종:1||약물 치료:1||염증성 근염:1||요도암:1||자가면역질환:1||자가이식:1||저분자량 헤파린:1||전립선암:1||전이:1||조혈모세포이식:1||진단및 치료 지침:1||치료지침:1||티로신키나제억제제:1||16S rRNA genebased metagenomics:1||후복막 고립성 골수외 형질세포종:1||Acute promyelocytic leukemia:1||Adiponectin:1||Advanced pancreatic cancer:1||Angiogenesis:1||Anticoagulants:1||

STATISTICS: Total View :1,227,222; Today View :826

RSS_1.0 RSS_2.0 ATOM_1.0

(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE